These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Comprehensive bench- and pilot-scale investigation of trace organic compounds rejection by forward osmosis.
    Author: Hancock NT, Xu P, Heil DM, Bellona C, Cath TY.
    Journal: Environ Sci Technol; 2011 Oct 01; 45(19):8483-90. PubMed ID: 21838294.
    Abstract:
    Forward osmosis (FO) is a membrane separation technology that has been studied in recent years for application in water treatment and desalination. It can best be utilized as an advanced pretreatment for desalination processes such as reverse osmosis (RO) and nanofiltration (NF) to protect the membranes from scaling and fouling. In the current study the rejection of trace organic compounds (TOrCs) such as pharmaceuticals, personal care products, plasticizers, and flame-retardants by FO and a hybrid FO-RO system was investigated at both the bench- and pilot-scales. More than 30 compounds were analyzed, of which 23 nonionic and ionic TOrCs were identified and quantified in the studied wastewater effluent. Results revealed that almost all TOrCs were highly rejected by the FO membrane at the pilot scale while rejection at the bench scale was generally lower. Membrane fouling, especially under field conditions when wastewater effluent is the FO feed solution, plays a substantial role in increasing the rejection of TOrCs in FO. The hybrid FO-RO process demonstrated that the dual barrier treatment of impaired water could lead to more than 99% rejection of almost all TOrCs that were identified in reclaimed water.
    [Abstract] [Full Text] [Related] [New Search]